Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the Prostate Cancer Outcomes Study (Q34765952)

4 August 2017

Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the Prostate Cancer Outcomes Study (English)

1 reference

4 August 2017

1 reference

Richard M Hoffman

7

0 references

David F. Penson

object named as

David F Penson

11

0 references

Mark S Litwin

10

object named as

Mark S Litwin

1 reference

4 August 2017

6

Ann S Hamilton

1 reference

4 August 2017

Timothy J Daskivich

1

1 reference

4 August 2017

Kang-Hsien Fan

2

1 reference

4 August 2017

Tatsuki Koyama

3

1 reference

4 August 2017

Peter C Albertsen

4

1 reference

4 August 2017

Michael Goodman

5

1 reference

4 August 2017

Janet L Stanford

8

1 reference

4 August 2017

Antoinette M Stroup

9

1 reference

4 August 2017

language of work or name

English

0 references

publication date

26 September 2014

1 reference

4 August 2017

1 reference

4 August 2017

85

1 reference

4 August 2017

1

1 reference

4 August 2017

92-100

1 reference

Commentary on: "Long-term functional outcomes after treatment for localized prostate cancer." Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Van Horn RL, Penson DF. Department of U

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Radical prostatectomy versus observation for localized prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Impact of comorbidity on survival among men with localized prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

NCCN clinical practice guidelines in oncology: prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Outcomes of localized prostate cancer following conservative management

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Guideline for the management of clinically localized prostate cancer: 2007 update.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Radical prostatectomy versus watchful waiting in early prostate cancer

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Overtreatment of men with low-risk prostate cancer and significant comorbidity

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Do patients consistently report comorbid conditions over time?: results from the prostate cancer outcomes study.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275422

Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer

26 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2014.07.003

Long-term functional outcomes after treatment for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2014.07.003

Quality of life and satisfaction with outcome among prostate-cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2014.07.003

Accuracy of life tables in predicting overall survival in patients after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2014.07.003

A Nomogram Predicting 10-Year Life Expectancy in Candidates for Radical Prostatectomy or Radiotherapy for Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2014.07.003

Determining cause of death in prostate cancer: are death certificates valid?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2014.07.003

The impact of co-morbidity on life expectancy among men with localized prostate cancer

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25261048

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25261048

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.UROLOGY.2014.07.003

1 reference

4 August 2017

1 reference

4 August 2017

1 reference